Hypohomocysteinemia: A Potentially Treatable Cause of Peripheral Neuropathology? - 11/01/12
, Michael D. Weiss, MD d, Peter A. Grant, MD e, David Scott Saperstein, MD f
Corresponding author.Résumé |
Perturbations of homocysteine metabolism are associated with increased risk for cardiovascular disease, stroke, dementia, and depression, among other major diseases. To assess the relationship between hypohomocysteinemia (HH) and idiopathic peripheral neuropathy (IPN), a retrospective review of 37,442 patients from a tertiary medical clinic was performed. Of patients with HH, 5.9% had IPN versus 0.6% of patients without IPN. Overall, 41% of patients with HH had IPN. These observations indicate that although HH is uncommon in the general population, there is a striking relationship between HH and the incidence of IPN. This article discusses the clinical ramifications of these findings.
Le texte complet de cet article est disponible en PDF.Keywords : Neuromuscular disease, Peripheral neuropathy, Homocysteine deficiency, Hypohomocysteinemia, Nutrition, Folate
Plan
Vol 23 - N° 1
P. 59-65 - février 2012 Retour au numéro
Article précédent
- The Effects of Active and Passive Stretching on Muscle Length
- Danny A. Riley, J.M. Van Dyke
- Regional and Whole-Body Dual-Energy X-Ray Absorptiometry to Guide Treatment and Monitor Disease Progression in Neuromuscular Disease
- Andrew J. Skalsky, Jay J. Han, Richard T. Abresch, Craig M. McDonald
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?